ALTSTATION.IO

Globe Life Inc. (GL) Stock Analysis

By Nova Skye | AltStation.io | Updated October 11, 2026

Price
$164.75
Change
-0.80%
Market Cap
$12.66B
Avg Volume
532.8K

Company Overview

Globe Life Inc. is an insurer headquartered in McKinney, Texas, operating within the life insurance branch of the financial services sector. The company sells straightforward coverage, including term, whole, and children’s life policies, alongside supplemental health plans covering cancer, heart conditions, accidents, and hospital stays. Their target customer base is strictly lower-middle and middle-income families across the United States. Distribution runs across four clear routes: direct-to-consumer channels, exclusive independent agents, general agency independent agents, and brokers.

Globe Life operates as a specialized niche player rather than a sprawling financial conglomerate. Their core edge is direct access to middle-income households that large diversified insurers routinely overlook, paired with a dedicated agent sales force. The downside to this focus is product concentration, as relying heavily on supplemental health and final expense coverage leaves them sensitive to consumer spending pullbacks. They win on simplicity and direct distribution, but they face constant pressure from standard life insurers competing for the same demographic.

Founded in 1900, the company has over 120 years of operating history and executed a major identity shift in August 2019 by changing its name from Torchmark Corporation to Globe Life Inc. The business currently operates across three core segments: Life Insurance, Supplemental Health Insurance, and Investments. They are not pivoting into speculative fintech models; they remain committed to traditional policy underwriting and cash collection. The bottom line comes down to steady execution across their agent networks and investment yield across those three distinct segments.

Key Financials
Market Cap
$12.66B
Revenue
$6.19B
EBITDA
$1.68B
Gross Margin
33.9%
Profit Margin
19.6%
Revenue Growth
8.0%
Total Cash
$455.38M
Total Debt
$3.43B
Free Cash Flow
$1.16B


52-Week Price Performance Analysis

Price Statistics
P/E Ratio
10.93
Forward P/E
9.99
Beta
0.44
52-Week High
$191.55
52-Week Low
$127.85
EPS
$15.07
50-Day Avg
$173.67
200-Day Avg
$157.91
Price/Book
2.06
GL 52-Week Stock Chart
Technical Analysis
GL trades at $164.75, placing it 58% of the way from its $126.81 52-week low to its $191.17 high. The stock is 14.12% below that high and 29.46% above the low. Price sits 2.29% below the 20-day moving average of $168.02, showing near-term weakness. Momentum is negative at 0.71% over five trading days and 3.90% over 20 trading days. Near-term support is $163.41, while resistance is $176.17.


Recent News and Developments

Morgan Stanley cuts Globe Life target to $197

Morgan Stanley analyst Bob Huang lowered Globe Life’s price target from $208 to $197 on October 5, a 5.29% cut. The firm kept its Overweight rating, so this is a more cautious valuation call, not a downgrade. Source: GuruFocus

Weiss Ratings trims Globe Life grade

Weiss Ratings downgraded Globe Life from Buy (B) to Buy (B-) on October 6. The stock retained a Buy rating despite the weaker letter grade. Source: PriceTargets.com

Globe Life schedules third-quarter earnings

Globe Life will release third-quarter 2026 results after the market closes on October 21. Its conference call is scheduled for October 22 at 11:00 a.m. Eastern. Source: Globe Life



Market Sentiment and Analyst Recommendations

Bull Case
Revenue is growing 8.0%, which gives the stock a fundamental growth engine despite recent price weakness. GL trades at 10.93 times earnings, a modest valuation relative to the analyst optimism surrounding the company. The consensus target is $192.91 versus the current $164.75 price, with estimates ranging from $166.00 to $225.00. All 11 analysts behind the supplied recommendation collectively rate the stock a buy. Morgan Stanley maintained its Overweight rating and set a $197 target, even after reducing that target from $208. The next catalyst is the third-quarter 2026 earnings release after the market closes on October 21, followed by the conference call on October 22.
Bear Case
GL has $3.43 billion in total debt against only $455.38 million in cash, creating a clear balance-sheet concern. The stock is below its $168.02 20-day moving average, with 20-day momentum at negative 3.90%. At $164.75, the price is also close to near-term support at $163.41, leaving little room before that level is tested. Morgan Stanley cut its target from $208 to $197, a 5.29% reduction, despite keeping an Overweight rating. Weiss Ratings also lowered its grade from Buy (B) to Buy (B-), another sign that outside assessments have become more cautious. The October 21 earnings report is an execution risk because the current buy thesis depends on the company supporting its 8.0% revenue growth and analyst expectations.
What to Watch
The main event is Globe Life’s third-quarter 2026 earnings release after the market closes on October 21. The conference call follows on October 22 at 11:00 a.m. Eastern and should provide the clearest test of the current thesis. Revenue growth is 8.0%, so investors should watch whether the reported business performance supports that pace. On the chart, $163.41 is the immediate level to defend; a move below it would break the supplied 30-day support. A recovery above the $168.02 20-day moving average would improve the near-term setup, while $176.17 remains the next resistance level. Investors should also track whether analyst targets continue moving lower after Morgan Stanley’s cut from $208 to $197 and Weiss Ratings’ move from Buy (B) to Buy (B-).
Analyst Consensus
BUY

Based on 11 analyst opinions
Low Target
$166.00
Mean Target
$192.91
High Target
$225.00


Earnings and Financial Data

Sector
Financial Services
Industry
Insurance – Life
Employees
3,695
Earnings & Dividends
Next Earnings
Oct 21, 2026
EPS (Trailing)
$15.07
Dividend Yield
79.0%
Payout Ratio
8.0%

Frequently Asked Questions

Is GL a good stock to buy?
GL has a buy recommendation from 11 analysts, 8.0% revenue growth, and a P/E ratio of 10.93. The takeaway is that the fundamental setup is attractive, but the stock’s negative short-term momentum argues against ignoring entry price.
What is GL’s price target?
The analyst target is $192.91, with individual targets ranging from $166.00 to $225.00. The takeaway is that analysts see upside from the current $164.75 price, although the low end of the range is close to the current level.
What are GL stock’s support and resistance levels?
Near-term support is the 30-day low of $163.41, while near-term resistance is the 30-day high of $176.17. The takeaway is that GL is currently trading much closer to support than resistance.
Is GL stock overvalued?
GL trades at a P/E ratio of 10.93 with revenue growth of 8.0%. The takeaway is that the supplied valuation and growth figures do not point to an obviously expensive stock.
How far is GL from its 52-week high?
GL is 14.12% below its $191.17 52-week high and 29.46% above its $126.81 low. The takeaway is that the stock remains well above its low but has not recovered to its peak.

Related Stock Reports

Disclaimer: This report is for informational purposes only and does not constitute financial advice. The analysis and opinions expressed are those of AltStation.io and should not be relied upon as the sole basis for investment decisions. Always conduct your own research and consult with a qualified financial advisor before making investment decisions. Past performance does not guarantee future results. Updated October 11, 2026.